Literature DB >> 28725075

Eosinophilic Esophagitis: Leaky Gullet or Leaky Gut?

David A Katzka1.   

Abstract

Eosinophilic esophagitis (EoE) is a food allergen disorder driven by antigen recognition in the gastrointestinal tract. The study by Warners et al., strongly supports the esophageal epithelium as the area of disturbed permeability and primary target for initiation of the TH2-induced allergic pathway. In contrast, small bowel assessment reveals a lack of clear change in aspects of permeability compared to controls. It is not clear, however, if the available testing used for this purpose accurately assesses the mechanisms by which antigen recognition may occur in this organ. As a result, the role of the small bowel in EoE remains unclear.

Entities:  

Mesh:

Year:  2017        PMID: 28725075     DOI: 10.1038/ajg.2017.136

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis.

Authors:  David A Katzka; Ravikanth Tadi; Thomas C Smyrk; Eesha Katarya; Anamay Sharma; Deborah M Geno; Michael Camilleri; Prasad G Iyer; Jeffrey A Alexander; Navtej S Buttar
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-27       Impact factor: 11.382

Review 2.  Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2015-02-07       Impact factor: 22.682

3.  Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests.

Authors:  Jonathan M Spergel; Timothy Andrews; Terri F Brown-Whitehorn; Janet L Beausoleil; Chris A Liacouras
Journal:  Ann Allergy Asthma Immunol       Date:  2005-10       Impact factor: 6.347

4.  Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study.

Authors:  Tamara Pozo-Rubio; Giada de Palma; Jorge R Mujico; Marta Olivares; Ascensión Marcos; María Dolores Acuña; Isabel Polanco; Yolanda Sanz; Esther Nova
Journal:  Nutr Hosp       Date:  2013 Mar-Apr       Impact factor: 1.057

5.  Risk factors for the development of atopic dermatitis and early wheeze.

Authors:  Iwona Stelmach; Monika Bobrowska-Korzeniowska; Katarzyna Smejda; Paweł Majak; Joanna Jerzynska; Wlodzimierz Stelmach; Kinga Polańska; Wojciech Sobala; Jolanta Krysicka; Wojciech Hanke
Journal:  Allergy Asthma Proc       Date:  2014 Sep-Oct       Impact factor: 2.587

6.  Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis.

Authors:  David A Katzka; Karthik Ravi; Debra M Geno; Thomas C Smyrk; Prasad G Iyer; Jeffrey A Alexander; Jerry E Mabary; Michael Camilleri; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 11.382

7.  Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation.

Authors:  Gerrit J M Hemmink; Lorenza Alvarez Herrero; Auke Bogte; Albert J Bredenoord; Jaques J Bergman; André J P M Smout; Bas L A M Weusten
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 2.566

8.  Early life exposures as risk factors for pediatric eosinophilic esophagitis.

Authors:  Elizabeth T Jensen; Michael D Kappelman; Hannah P Kim; Tamar Ringel-Kulka; Evan S Dellon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-07       Impact factor: 2.839

9.  Intestinal permeability in patients with atopic eczema.

Authors:  I Bjarnason; S K Goolamali; A J Levi; T J Peters
Journal:  Br J Dermatol       Date:  1985-03       Impact factor: 9.302

10.  Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients.

Authors:  M J Warners; B J Vlieg-Boerstra; J Verheij; B D van Rhijn; M T J Van Ampting; L F Harthoorn; W J de Jonge; A J P M Smout; A J Bredenoord
Journal:  Aliment Pharmacol Ther       Date:  2017-01-23       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.